News
Infiltration and extravasation are one of the most destructive complications to the neonate's fragile skin. This article reviews multiple aspects of infiltration and extravasation injury.
Quality of Life Matters: It Is Time to Integrate Scalp Cooling in Routine Clinical Practice There is a clear economic incentive for dose rounding down to a vial size to reduce product wastage.
Recently at ASCO 2019, ETNA investigators reported that the secondary endpoint of 5-year EFS was not statistically significantly different between neoadjuvant nab-paclitaxel compared to s-paclitaxel.
AbbVie is already running a phase 3 confirmatory study on Emrelis in c-Met-overexpressing NSCLC dubbed TeliMET NSCLC-01, which pits the ADC against the chemotherapy docetaxel. Emrelis represents ...
Telisotuzumab vedotin is also being assessed as a monotherapy against docetaxel in patients with previously treated c-Met–overexpressing NSCLC in the TeliMET NSCLC-01 randomized phase 3 global ...
Aims: To determine the maximum tolerated dose (MTD), safety and anti-tumor activity of afatinib combined with docetaxel in advanced cancer. Patients & methods: The MTD was determined from dose ...
Sports teacher Glenn Colmer, 51, was hit by a massive, sudden seizure at his home in Southampton on February 18, and was rushed to hospital. Scans revealed a mass on his brain-and four days after ...
"While the docetaxel combination demonstrated modest activity, Penetrium™'s mechanism is most compelling when paired with immunotherapy," stated a Hyundai ADM spokesperson. "Both scientific rationale ...
qDepartment of Hepatogastroenterology and Digestive Oncology, Nancy University Hospital, University of Lorraine, Vandoeuvre-lès-Nancy, France rDepartment of Gastroenterology and Digestive Oncology, ...
Aim The aim of this project was to perform an evaluation of the voluntary incident reporting system in place at a tertiary care paediatric hospital, with respect to extravasation injury. This was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results